IDI Insurance: How Much Capital Headroom Really Remains After Dividends and Tier 2 Funding
IDI Insurance ends 2025 with NIS 1.268 billion of equity and a 133% solvency ratio in the latest published snapshot, but the headroom that really remains for distributions is narrower than the headline suggests. This follow-up separates capital built through earnings from the portion that still depends on a market-sensitive solvency model, a high payout pace, and Tier 2 funding that is already running into its practical regulatory ceiling.
What This Follow-Up Is Isolating
The main article already argued that underwriting moved back to the center, but capital still sets the ceiling. This follow-up isolates only that question: how much of the capital cushion that shows up in the filings is still really there once dividends and Tier 2 actions are taken seriously.
That is a different question from earnings. For an insurer, book equity, solvency headroom, and distribution capacity are not the same thing. IDI ended 2025 with NIS 1.268 billion of equity, after roughly NIS 381.1 million of profit, about NIS 235.0 million of dividends, and about NIS 3.5 million of share-based compensation expense. But the actual distribution test runs through solvency, not through accounting equity.
There are four points a fast reader can easily miss:
- The latest formal solvency snapshot in the annual package is dated June 30, 2025, not December 31, 2025.
- 133% looks comfortable against the 100% floor, but against the board's 120% target it leaves only 13 percentage points and about NIS 195.2 million of excess capital.
- Tier 2 strengthened the capital plumbing, but it did not create unlimited fresh distribution room. The April 2025 NIS 185 million bank Tier 2 raise added only about NIS 105 million to recognized capital for SCR purposes, and the September issuance did not increase recognized capital because the cap had already become binding.
- The payout pace has already consumed part of the cushion. The report attributes roughly NIS 250 million of dividends tied to 2025 earnings, which is about 66% of 2025 profit.
What the Solvency Snapshot Says, and What It Does Not
The core solvency number is straightforward. In the solvency report as of June 30, 2025, IDI showed own funds for SCR purposes of NIS 1,951.8 million against an SCR requirement of NIS 1,463.8 million. That produces NIS 488.0 million of excess capital and a 133% solvency ratio.
But for the distribution debate, the more important number is not the excess over the minimum requirement. It is the excess over the board's own target. That picture is much tighter. The board target is 120%, without transition measures and without the equity-shock adjustment, and the excess above that target is only NIS 195.2 million.
That chart captures the real issue. Against the raw SCR line, the cushion looks strong. Against the board's payout target, it is far less generous. More importantly, excess capital above the board target actually slipped from about NIS 200.7 million in the prior published bridge to about NIS 195.2 million in the June 30, 2025 snapshot. In other words, even while the company was building capital and taking capital actions, the room that really sat above the payout threshold did not expand.
There is also an explicit caution in the filing itself. The report describes the solvency model as highly sensitive to market variables and other assumptions, and the capital note says there is no certainty the company will meet that ratio at every point in time. It also says that after June 30, 2025, macro developments occurred in Israel and abroad whose full effect on solvency still could not be quantified.
That is the crucial distinction: the NIS 195.2 million is real headroom, but it is headroom as of a specific date, based on that day's investment and liability mix, inside a model that management itself describes as very market-sensitive.
Tier 2 Funding: More Capital Plumbing Than Fresh Distribution Capacity
The right way to read 2025 is not only through earnings, but through the mechanics of Tier 2 capital. IDI made three material moves:
| Date | Action | Amount | What it actually did to headroom |
|---|---|---|---|
| April 2025 | Subordinated bank loans | NIS 185 million | Only about NIS 105 million were included in recognized own funds for SCR purposes after the Tier 2 cap |
| September 2025 | Series Z subordinated debt issuance | About NIS 337.7 million net | Recognized as Tier 2, but did not increase recognized own funds for SCR because the same cap was binding |
| November 2025 | Full early redemption of the older subordinated series | About NIS 315.9 million including accrued interest | Did not change the solvency ratio for the same reason |
That table tells a less intuitive story than the headline "capital was raised." In April, the company raised NIS 185 million, but only roughly 57% of that amount entered recognized own funds for SCR purposes. In September, it added a larger subordinated layer, yet the filing explicitly says that the issuance had no effect on own funds for SCR purposes. In November, it redeemed an older series, and that also had no effect on the solvency ratio.
The practical conclusion is that these moves improved the structure of the capital pipeline and the maturity profile of funding, but they did not create another jump in distribution headroom. Put differently, Tier 2 helped IDI manage its capital stack, but it did not solve the question of how much capital really remains above the payout target.
That is why those raises should not be counted as free upside for shareholders. Once the regulatory cap on Tier 2 starts binding, subordinated funding stops being a simple lever for wider distributions and becomes mainly a refinancing and capital-management tool.
The Payout Pace: Which Dividend Belongs to 2024, Which to 2025
It is also easy to misread the dividend line. During 2025 the company actually paid four dividends: NIS 60 million in March, about NIS 55 million in May, about NIS 60 million in August, and about NIS 60 million in November. After the balance-sheet date it declared another NIS 75 million dividend.
But those amounts do not all belong to the same earnings year. The report explicitly says that the March 2025 dividend of NIS 60 million was deducted from recognized capital as calculated at December 31, 2024. By contrast, the May, August, and November 2025 dividends plus the dividend declared at the end of March 2026 add up to about NIS 250 million, and the company says that together they represent about 66% of 2025 profit.
That chart matters because it shows two different things at once:
- The annual cash pace going out to shareholders was already aggressive. About NIS 235 million were distributed during 2025 itself.
- The payout pace on 2025 earnings was also aggressive. The March 2026 dividend takes the amount tied to 2025 profit to about NIS 250 million, or roughly 66% of profit.
This is exactly where double-counting becomes a risk. If someone looks at 133% in June 2025, mentally adds all 2025 and 2026 dividends on top of that number, and also treats the NIS 250 million as if it were still sitting untouched inside the solvency cushion, they are reading the capital picture incorrectly. Some of those payouts were already deducted from the regulatory bridge, and some had already gone out the door in cash.
What Looks Durable, and What Still Depends on Markets
Not all of IDI's capital headroom is soft. Quite the opposite. Equity rose 13% in 2025 to NIS 1.268 billion while the company still distributed about NIS 235 million. That is evidence that the business created real capital during the year rather than only recycling subordinated debt. The board report also says that the improvement in own funds for SCR purposes came mainly from business growth across all segments and investment gains in the proprietary portfolio.
But this is exactly where the line between the durable and the market-sensitive parts runs:
- The more durable layer is the company's ability to generate profits that keep rebuilding capital even after distributions.
- The more sensitive layer is the translation of that capital into the solvency ratio, because the ratio itself depends on investment mix, assumptions, and a model the company describes as highly sensitive to markets.
So if the question is answered honestly, the answer is this: IDI now has a stronger capital base than it had at the start of the year, but the distributable cushion that the market can really verify above the board target is still not especially wide, and part of it relies on a mid-2025 snapshot inside a model that management itself warns can move materially.
Bottom Line
The right reading is not that capital is weak, and not that the dividends are reckless simply because they are large. The right reading is more precise: IDI built real capital in 2025, but the distribution cushion that remains above the board target is not unlimited, and it still sits on top of a market-sensitive solvency model and a Tier 2 stack that is already close to its practical ceiling.
That has a simple implication for shareholders. Part of the headroom looks durable because equity kept growing even after a heavy payout year. Another part still looks market-sensitive because the latest regulatory snapshot is dated June 30, 2025, and the company itself says there is no certainty it will stay at that target ratio at every point in time.
That is why the next solvency report matters more than another dividend headline. If IDI shows that the ratio stayed comfortable even after the 2025 and early 2026 payout pace, then the cushion can be treated as genuinely strong. If not, part of the 2025 headroom will turn out to have been more of a favorable market snapshot than a permanent license for a much wider distribution policy.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.